These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3581610)

  • 1. Effect of reserpine on salivary gland radioiodine uptake in thyroid cancer.
    Levy HA; Park CH
    Clin Nucl Med; 1987 Apr; 12(4):303-7. PubMed ID: 3581610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary gland protection with sialagogues: a case study.
    Van Nostrand D; Atkins F; Bandaru VV; Chennupati SP; Moreau S; Burman K; Wartofsky L
    Thyroid; 2009 Sep; 19(9):1005-8. PubMed ID: 19500022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication.
    Allweiss P; Braunstein GD; Katz A; Waxman A
    J Nucl Med; 1984 Jul; 25(7):755-8. PubMed ID: 6737074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.
    Jentzen W; Balschuweit D; Schmitz J; Freudenberg L; Eising E; Hilbel T; Bockisch A; Stahl A
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2298-306. PubMed ID: 20625723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].
    Macioszek A; Baczyk M; Kopeć T; Sowiński J
    Endokrynol Pol; 2008; 59(5):403-10. PubMed ID: 18979451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
    Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
    Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
    [No Abstract]   [Full Text] [Related]  

  • 9. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
    Caglar M; Tuncel M; Alpar R
    Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer.
    Son H; Lee SM; Yoon RG; Lee H; Lee I; Kim S; Chung WY; Lee JW
    Hell J Nucl Med; 2017; 20(1):62-70. PubMed ID: 28315910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dramatic parotid uptake of I-131 on a diagnostic whole-body scan.
    Carlisle MR; McDougall IR
    Clin Nucl Med; 2000 Nov; 25(11):895-7. PubMed ID: 11079586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chewing-gum on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine.
    Haghighatafshar M; Nowshad R; Etemadi Z; Ghaedian T
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):321-325. PubMed ID: 29696945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Bleckmann C; Brenner W; Lassmann S; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Feb; 175(2):57-61. PubMed ID: 10065139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilocarpine effect on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine.
    Haghighatafshar M; Ghaedian M; Etemadi Z; Entezarmahdi SM; Ghaedian T
    Nucl Med Commun; 2018 May; 39(5):430-434. PubMed ID: 29517578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.
    Ma C; Xie J; Chen Q; Wang G; Zuo S
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007956. PubMed ID: 19821441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer.
    Jentzen W; Schneider E; Freudenberg L; Eising EG; Görges R; Müller SP; Brandau W; Bockisch A
    Nucl Med Commun; 2006 Aug; 27(8):669-76. PubMed ID: 16829767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.
    Bohuslavizki KH; Brenner W; Klutmann S; Hübner RH; Lassmann S; Feyerabend B; Lüttges J; Tinnemeyer S; Clausen M; Henze E
    J Nucl Med; 1998 Jul; 39(7):1237-42. PubMed ID: 9669401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary evaluation in radioactive I
    Daniel FI; Lima LD; Grando LJ; Castro R; Cordeiro EAK; Dos Santos CR
    Acta Odontol Scand; 2018 Mar; 76(2):148-152. PubMed ID: 29125000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.
    Kim YM; Choi JS; Hong SB; Hyun IY; Lim JY
    Head Neck; 2016 Jan; 38(1):51-8. PubMed ID: 24995941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
    Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
    J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.